Exabis Library
Welcome to the e-CCO Library!
DOP013: An IBD associated variant in PTPN2 promotes inflammatory responses but enhances the anti-inflammatory effect of spermidine
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP013: Definition of therapeutic response criteria using MRI in Crohn’s Disease patients treated with anti-TNF therapy: A multicenter prospective study (the IRMA study)
2017
ECCO'17 Barcelona
1
DOP014: Impact of genetic variation on gene and protein expression in Crohn’s Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP014: Nutritional optimisation of pre-surgical Crohn’s disease patients with enteral nutrition significantly decreases length of stay and need for a stoma
2016
ECCO'16 DOP
1
DOP014: Transmural healing is better than mucosal healing in Crohn's Disease
2017
ECCO'17 Barcelona
1
DOP015: Dysregulation of cell-type specific long ncRNA in the ileum of treatment naïve early onset Crohn Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP015: International differences in gastroenterologists’ perspective on stopping therapy for patients with Crohn’s Disease
2017
ECCO'17 Barcelona
1
DOP015: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn’s disease
2016
ECCO'16 DOP
1
DOP016: Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of Inflammatory Bowel Diseases: Results from the multicenter European TEDDY study
2017
ECCO'17 Barcelona
1
DOP016: Metagenomic analysis of intestinal mucosa revealed an IBD-specific shift in the eukaryotic gut virome composition at early stages of gut inflammation
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP017: Colectomy Free Survival is Independent of Initial Infliximab Dosing Strategy in Hospitalised Ulcerative Colitis Patients
2016
ECCO'16 DOP
1
DOP017: Increased intestinal aryl hydrocarbon receptor expression and pathway sensitivity in Crohn's Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP017: Patterns of anti-TNF use and associated treatment outcomes in Inflammatory Bowel Disease patients: Results from an analysis of Dutch health insurance claims data
2017
ECCO'17 Barcelona
1
DOP018: Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn’s Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP018: Effect of adalimumab on extraintestinal manifestations among patients with Ulcerative Colitis in a clinical practice setting: Results from INSPIRADA
2017
ECCO'17 Barcelona
1
DOP019: Effect of vedolizumab treatment on extraintestinal manifestations in patients with Crohn’s Disease: A GEMINI 2 post hoc analysis
2017
ECCO'17 Barcelona
1
DOP019: Efficacy of Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
2016
ECCO'16 DOP
1
DOP019: Immunomodulators reduce the risk of surgery and hospitalization in Crohn’s Disease in a prospective European population-based inception cohort – the Epi-IBD cohort
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1